10.89.Z - Production of other food products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 11,2 | 31,4 | 179,4 | |
Gross profit (loss) | 72,2 | 10,7 | 34,6 | 223,2 |
EBITDA | 73,7 | 10,7 | 34,6 | 223,2 |
Short time liabilities | 27,2 | 15,5 | 9,4 | -39 |
Other operating costs | 1,2 | 1,2 | 2,5 | |
Income tax | 0 | |||
Equity capital | 27,1 | 33,3 | 65,2 | 96 |
Operating profit (EBIT) | 73,7 | 10,7 | 34,6 | 223,2 |
Assets | 54,3 | 48,7 | 74,7 | 53,2 |
Net profit (loss) | 72,2 | 10,7 | 32 | 198,1 |
Cash | 12,6 | 8,8 | 16,8 | 91,4 |
Net income from sale | 353,4 | 281,2 | 363,5 | 29,3 |
Liabilities and provisions for liabilities | 27,2 | 15,5 | 9,4 | -39 |
Working assets | 54,3 | 48,7 | 74,7 | 53,2 |
Other income costs | 0,7 | 4,5 | 570,9 | |
Depreciation | 0 | 0 | 0 | 0 |
Basic operational activity income | 21,3 | |||
% | % | % | p.p. | |
Profitability of capital | 266,4 | 32,2 | 49 | 16,8 |
Equity capital to total assets | 49,9 | 68,3 | 87,4 | 19,1 |
Gross profit margin | 20,4 | 3,8 | 9,5 | 5,7 |
EBITDA Margin | 20,9 | 3,8 | 9,5 | 5,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 28 | 20 | 9 | -11 |
Current financial liquidity indicator | 1.9958372116088867 | 3.1524226665496826 | 7.9151530265808105 | 4,7 |
Net dept to EBITDA | -0.170852392911911 | -0.8168647885322571 | -0.4839029312133789 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane